vs
通用电气医疗（OPCH）与罗克韦尔自动化（ROK）财务数据对比。点击上方公司名可切换其他公司
罗克韦尔自动化的季度营收约是通用电气医疗的1.6倍（$2.1B vs $1.4B），罗克韦尔自动化净利率更高（14.5% vs 3.4%，领先11.1%），罗克韦尔自动化同比增速更快（11.9% vs 1.3%），过去两年通用电气医疗的营收复合增速更高（4.9% vs -0.5%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
罗克韦尔自动化是总部位于美国威斯康星州密尔沃基的工业自动化及数字化转型技术提供商，旗下拥有Allen-Bradley、FactoryTalk软件、LifecycleIQ服务等核心品牌，全球员工约2.7万人，服务覆盖100多个国家和地区的客户。
OPCH vs ROK — 直观对比
营收规模更大
ROK
是对方的1.6倍
$1.4B
营收增速更快
ROK
高出10.6%
1.3%
净利率更高
ROK
高出11.1%
3.4%
两年增速更快
OPCH
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $2.1B |
| 净利润 | $45.3M | $305.0M |
| 毛利率 | 19.4% | 48.3% |
| 营业利润率 | 5.4% | 20.7% |
| 净利率 | 3.4% | 14.5% |
| 营收同比 | 1.3% | 11.9% |
| 净利润同比 | -3.0% | 65.8% |
| 每股收益（稀释后） | $0.29 | $2.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPCHROK
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.4B | $2.3B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.3B | $1.9B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.2B | $2.1B |
净利润OPCHROK
| Q1 26 | $45.3M | — | ||
| Q4 25 | $58.5M | $305.0M | ||
| Q3 25 | $51.8M | $138.0M | ||
| Q2 25 | $50.5M | $295.0M | ||
| Q1 25 | $46.7M | $252.0M | ||
| Q4 24 | $60.1M | $184.0M | ||
| Q3 24 | $53.9M | $239.1M | ||
| Q2 24 | $53.0M | $232.0M |
毛利率OPCHROK
| Q1 26 | 19.4% | — | ||
| Q4 25 | 19.3% | 48.3% | ||
| Q3 25 | 19.0% | 69.4% | ||
| Q2 25 | 19.0% | 40.9% | ||
| Q1 25 | 19.7% | 40.5% | ||
| Q4 24 | 21.3% | 38.4% | ||
| Q3 24 | 20.1% | 37.9% | ||
| Q2 24 | 20.3% | 38.8% |
营业利润率OPCHROK
| Q1 26 | 5.4% | — | ||
| Q4 25 | 6.2% | 20.7% | ||
| Q3 25 | 5.9% | 2.7% | ||
| Q2 25 | 5.8% | 16.0% | ||
| Q1 25 | 5.9% | 14.9% | ||
| Q4 24 | 6.9% | 17.1% | ||
| Q3 24 | 6.7% | 13.5% | ||
| Q2 24 | 6.6% | 12.4% |
净利率OPCHROK
| Q1 26 | 3.4% | — | ||
| Q4 25 | 4.0% | 14.5% | ||
| Q3 25 | 3.6% | 6.0% | ||
| Q2 25 | 3.6% | 13.8% | ||
| Q1 25 | 3.5% | 12.6% | ||
| Q4 24 | 4.8% | 9.8% | ||
| Q3 24 | 4.2% | 11.7% | ||
| Q2 24 | 4.3% | 11.3% |
每股收益（稀释后）OPCHROK
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.37 | $2.69 | ||
| Q3 25 | $0.32 | $1.24 | ||
| Q2 25 | $0.31 | $2.60 | ||
| Q1 25 | $0.28 | $2.22 | ||
| Q4 24 | $0.36 | $1.61 | ||
| Q3 24 | $0.31 | $2.09 | ||
| Q2 24 | $0.30 | $2.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.3M | $444.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $3.7B |
| 总资产 | $3.4B | $11.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OPCHROK
| Q1 26 | $177.3M | — | ||
| Q4 25 | $232.6M | $444.0M | ||
| Q3 25 | $309.8M | $468.0M | ||
| Q2 25 | $198.8M | $495.0M | ||
| Q1 25 | $171.4M | $456.0M | ||
| Q4 24 | $412.6M | $477.0M | ||
| Q3 24 | $483.0M | $471.3M | ||
| Q2 24 | $376.9M | $407.0M |
总债务OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $1.2B | $2.6B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | $2.6B | ||
| Q2 24 | $1.1B | — |
股东权益OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $3.7B | ||
| Q3 25 | $1.4B | $3.7B | ||
| Q2 25 | $1.4B | $3.5B | ||
| Q1 25 | $1.4B | $3.4B | ||
| Q4 24 | $1.4B | $3.4B | ||
| Q3 24 | $1.4B | $3.5B | ||
| Q2 24 | $1.4B | $3.3B |
总资产OPCHROK
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | $11.2B | ||
| Q3 25 | $3.5B | $11.2B | ||
| Q2 25 | $3.4B | $11.2B | ||
| Q1 25 | $3.3B | $11.0B | ||
| Q4 24 | $3.4B | $10.9B | ||
| Q3 24 | $3.4B | $11.2B | ||
| Q2 24 | $3.3B | $11.2B |
负债/权益比OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.86× | 0.72× | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.78× | 0.73× | ||
| Q2 24 | 0.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $234.0M |
| 自由现金流经营现金流 - 资本支出 | — | $170.0M |
| 自由现金流率自由现金流/营收 | — | 8.1% |
| 资本支出强度资本支出/营收 | — | 3.0% |
| 现金转化率经营现金流/净利润 | — | 0.77× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | $258.4M | $234.0M | ||
| Q3 25 | $139.4M | $454.0M | ||
| Q2 25 | $90.3M | $527.0M | ||
| Q1 25 | $-7.2M | $199.0M | ||
| Q4 24 | $36.1M | $364.0M | ||
| Q3 24 | $160.4M | $432.3M | ||
| Q2 24 | $195.7M | $279.1M |
自由现金流OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | — | $170.0M | ||
| Q3 25 | $130.2M | — | ||
| Q2 25 | $81.2M | $489.0M | ||
| Q1 25 | $-16.6M | $171.0M | ||
| Q4 24 | $25.8M | $293.0M | ||
| Q3 24 | $150.7M | — | ||
| Q2 24 | $185.9M | $238.4M |
自由现金流率OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | — | 8.1% | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 5.7% | 22.8% | ||
| Q1 25 | -1.2% | 8.5% | ||
| Q4 24 | 2.0% | 15.6% | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 15.1% | 11.6% |
资本支出强度OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | — | 3.0% | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.6% | 1.8% | ||
| Q1 25 | 0.7% | 1.4% | ||
| Q4 24 | 0.8% | 3.8% | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.8% | 2.0% |
现金转化率OPCHROK
| Q1 26 | — | — | ||
| Q4 25 | 4.42× | 0.77× | ||
| Q3 25 | 2.69× | 3.29× | ||
| Q2 25 | 1.79× | 1.79× | ||
| Q1 25 | -0.15× | 0.79× | ||
| Q4 24 | 0.60× | 1.98× | ||
| Q3 24 | 2.98× | 1.81× | ||
| Q2 24 | 3.69× | 1.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPCH
暂无分部数据
ROK
| Productsand Solutions | $1.9B | 89% |
| Lifecycle Services Segment | $259.0M | 12% |
